moderna emergency use authorization

News

FDA, COVID and Moderna

Moderna gets full US approval for COVID shot in at-risk children 6 months and older

The U.S. Food and Drug Administration has granted full approval for Moderna's COVID-19 vaccine, Spikevax, in children aged 6 months through 11 years who are at an increased risk of the disease, the company said on Thursday.

STAT · 1d

FDA grants full approval to Moderna’s Covid vaccine for children but limits eligibility

Just The News · 2d

In era of skepticism, FDA clears Moderna COVID vaccination for some kids up to 11 years old

ABC7 San Francisco1d

Moderna seeks emergency use authorization for Covid-19 vaccine for ...

NEW YORK -- Moderna is seeking emergency use authorization from the US Food and Drug Administration for its Covid-19 vaccine for children 6 months through 5 years of age, the company said ...

MRNA Stock Up on Full FDA Nod for COVID-19 Jab in Pediatric Patients

Moderna stock jumps 4.5% as the FDA grants full approval for its COVID-19 vaccine in high-risk individuals aged six months to ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results

News

FDA, COVID and Moderna

Trending now